|
3946
|
Altiratinib
|
Balanced inhibitor for MET, TIE2 (TEK), and VEGFR2 (KDR) kinases |
Inquire
|
|
1916
|
AMG 208
|
Inhibitor of c-MET receptor tyrosine kinase (RTK) |
€95.00
|
|
3945
|
AMG-337
|
Potent and exquisitely selective inhibitor of wild-type and some mutant forms of c-Met |
Inquire
|
|
1838
|
ARQ 197
|
c-MET tyrosine kinase Inhibitor |
€90.00
|
|
4040
|
BMS-777607
|
potent, selective and orally bioavailable c-Met inhibitor |
Inquire
|
|
4266
|
BPI-9016M
|
Potent, orally active, and selective c-Met and AXL inhibitor |
Recently added
|
Inquire
|
|
3423
|
Capmatinib
|
Highly potent, selective, ATP competitive and orally bioavailable c-MET inhibitor |
€80.00
|
|
1660
|
Crizotinib
|
c-MET Inhibitor; NPM-ALK inhibitor |
€70.00
|
|
1582
|
Foretinib
|
c-MET and VEGFR2 tyrosine kinase inhibitor |
€90.00
|
|
2553
|
LY 2801653
|
Orally bioavailable multi-kinase inhibitor with potent activity against c-MET |
€120.00
|
|
3975
|
MGCD265 dihydrochloride
|
Orally active, potent MET/SMO dual inhibitor |
€130.00
|
|
1583
|
PF 04217903 mesylate
|
c-MET tyrosine kinase Inhibitor |
€80.00
|
|
1914
|
SGX 523
|
ATP-competitive inhibitor of c-MET |
€120.00
|
|
1581
|
SU 11274
|
ATP-competitive inhibitor of c-MET |
€90.00
|
|
3864
|
Volitinib dihydrochloride
|
ATP-competitive small molecule c-Met kinase inhibitor |
Inquire
|